Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current strategies for managing interstitial cystitis.

C Lowell Parsons1

  • 1Division of Urology, UCSD Medical Center, San Diego, CA 92103-8897, USA. bjwelch@ucsd.edu

Expert Opinion on Pharmacotherapy
|March 5, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) Diagnosis: Current Limitations and a Pragmatic Clinical Diagnostic Definition.

Neurourology and urodynamics·2025
Same author

Subclinical Infection of the Silicone Breast Implant Surface as a Possible Cause of Capsular Contracture.

Aesthetic plastic surgery·2020
Same author

Role of urinary cations in the etiology of interstitial cystitis: A multisite study.

International journal of urology : official journal of the Japanese Urological Association·2020
Same author

Chronic scrotal pain: A variable symptom of interstitial cystitis/bladder pain syndrome.

Urology annals·2019
Same author

Editorial Comment.

The Journal of urology·2017
Same author

Increased toxic urinary cations in males with interstitial cystitis: a possible cause of bladder symptoms.

World journal of urology·2016

Interstitial cystitis (IC) can be successfully treated with multimodal therapy. A new intravesical solution combining heparin or pentosan polysulfate with lidocaine and sodium bicarbonate offers immediate symptom relief.

Area of Science:

  • Urology
  • Pharmacology

Background:

  • Interstitial cystitis (IC) is a common condition affecting many patients.
  • Effective symptom control and disease management are achievable.

Purpose of the Study:

  • To outline a multimodal treatment regimen for interstitial cystitis.
  • To introduce a novel intravesical therapeutic solution for IC symptom management.

Main Methods:

  • Multimodal medical regimen centered on heparinoid therapy.
  • Supplementation with oral medications for neural upregulation and allergy control.
  • Introduction of an intravesical solution containing pentosan polysulfate or heparin, lidocaine, and sodium bicarbonate.

Main Results:

  • Heparinoid therapy forms the basis of successful IC treatment.

Related Experiment Videos

  • Oral medications address specific patient needs like neural upregulation and allergies.
  • The intravesical solution provides rapid, albeit temporary, symptom relief.

    • Conclusions:

    • A multimodal approach, including heparinoid therapy and targeted oral medications, is effective for interstitial cystitis.
    • The novel intravesical therapeutic solution shows promise for immediate symptom alleviation in IC patients.